Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug VAGIFEM

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novo Nordisk drug VAGIFEM

Annual Drug Patent Expirations for VAGIFEM
Annual Drug Patent Expirations for VAGIFEM

Vagifem is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.

VAGIFEM drug price trends.

Drug patent litigation for VAGIFEM.

This drug has thirteen patent family members in ten countries.

The generic ingredient in VAGIFEM is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novo Nordisk drug VAGIFEM
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions